FOCISed Courses

FOCIS2025 1920x180 MicrositeBanner

FOCISed Courses

The two education programs held before the FOCIS 2025 Annual Meeting are listed below.

First, on Monday, we will hold the Systems Immunology Course (full day).

Next, on Tuesday, the Cancer Immunity & Immunotherapy Course (full day) will take place.

Please note: advanced registration is required for all education programs. Register for one or two days of education – package rates are available. Additionally, you can add your FOCIS 2025 Annual Meeting registration at the same time. Don’t wait – register today!

FOCIS 2025 Pre-Meeting Courses Registration Rates

Monday, June 23
Systems Immunology

Tuesday, June 24
Cancer Immunity and Immunotherapy

Rates by Category Single Course Two-Course Package
Trainee Member $230 $347
Trainee Non-Member $314 $453
Regular Member $300 $486
Regular Non-Member $480 $689
Industry Member $578 $765
Industry Non-Member $787 $974

2025 FOCISEd course photos

Systems Immunology Course

Attend this course to first obtain a conceptual framework of the main modeling, analysis and visualization technologies, along with methodological principles for their application to translational research projects. Additionally, The course will also provide a better basic understanding of modern statistical and mathematical concepts necessary for their analysis and interpretation.

Specifically, the course is aimed at scientists involved or interested in the use of multi-dimensional data generated by modern genomics and proteomics technologies such as mass/flow cytometry, next-generation sequencing, and microarrays.

2025 FOCISEd course photos (1)

Cancer Immunity & Immunotherapy Course

The course will begin by reviewing tumor immunology as the scientific foundation for the current practice of cancer immunotherapy, focusing on fundamental principles, clinical advances, limitations, and opportunities to accelerate clinical progress.

Furthermore. this course is designed for translational researchers and scientists, practicing clinicians, trainees, and individuals in biotechnology and pharmaceutical companies interested in immuno-oncology and the development of immunotherapies for cancer.

Skip to toolbar